Overview
We are currently recruiting for an Engineering Administrator to join the Engineering team. The purpose of this role is ensuring adherence to the maintenance schedule with internal and external resource assignment.
Our Engineering team lead various buildings and infrastructure changes across all our workplaces. This includes external and internal redevelopment projects, equipment maintenance and repairs while ensuring our premises remain secure, safe and clean for our employees to work.
Responsibilities
* Administration of the asset maintenance scheduling software
* Ensuring all planned maintenance is completed as scheduled, providing monthly reports on completion rates and highlighting any issues
* Purchasing activities for engineering critical spares
* Working closely with various departments to organise asset availability ensuring maximum equipment availability.
* Managing Contractors through permits to work
Qualifications
* Minimum Education GCSE (or equivalent) Maths & English
* Working knowledge of the preventative maintenance process in a GMP environment (preferred)
* Previous experience working within an Enterprise Resource Planning system (ERP) and or CMMS
* Ability to interpret technical documentation and to problem solve
* Microsoft Office expertise within MS Word & Excel, Outlook & MS Teams
* Good communication and numerical reasoning skills
About Us
OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.
OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.
What’s in it for you
* Highly competitive total reward packages
* Wellbeing programmes
* Development opportunities
* Welcoming, friendly, supportive colleagues
* A diverse and inclusive working environment
* Our values are: Responsible, Responsive, Resilient, Respect
* State of the art laboratory and manufacturing facilities
Collaborate. Contribute. Change lives
Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).
Oxford Biomedica collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
#J-18808-Ljbffr